Overview and registration fees

This meeting is aimed at those with an interest in Clinical Biochemistry. It aims to provide an update on a range of current analytical and clinical issues, and will challenge some conventional thinking.The topics covered will look at interpretation of results, and also factors that can cause spurious results to be produced.  There will be an update on topical areas in paediatric endocrinology as well as a session challenging some common (mis)conceptions.  The final session of the day will look at the impact of laboratory medicine on patient outcomes.  

RCPath members: £198.00
Non RCPath members: £275.00
Concessionary (BMS/Trainees/Retired): £106.00


09.00 Registration & Coffee

09.25 Welcome and Introduction - Dr Kathryn Ryan, Belfast Health & Social Care NHS Trust

Interference in Laboratory Tests

Chair: Dr Chris Chaloner, Manchester

09.30 Pitfalls in the measurement and interpretation of thyroid function tests - Dr Mark Gurnell, University of Cambridge

10.05 Interferences in routine clinical chemistry tests - Dr Phil Monaghan, Manchester

10.40 Monoclonal antibody interference in protein electrophoresis - Dr Jo Sheldon, South West London

11.15 Mid-morning refreshments

Challenges in Paediatrics

Chair: Dr Chris Chaloner, Manchester

11.40 Cortisol assays - fitness for purpose paediatrics - Mrs Lesley Tetlow, Manchester

12.10 Paediatric Endocrinology - when to panic? - Dr Les Perry

12.40 Lunch & networking

Challenging Conventions

Chair: Mrs Sarah Cleary, Lanarkshire

13.30 Is the Friedwald Equation still relevant? - Dr Dermot Neely, Newcastle

14.05 A coffee a day keeps the doctor away - Professor Peter Hayes, Edinburgh

14.45 Afternoon refreshments

15.05 Welcome from Professor Jo Martin, President, RCPath and short talk on eCPD App

Laboratory Medicine Improving Patient Care

15.15 Introduction and Overview - Demand optimisation: defining value in laboratory services - Dr Bernie Croal, Aberdeen Royal Infirmary

15.25 Relating lab testing to outcomes – delivering patient-centred laboratory medicine - Mr Mike Hallworth, Shrewsbury

15.55 Better patient outcomes by improving the laboratory-clinician interface - Dr Danielle Freedman, Luton & Dunstable Hospital

16.25 Close


Speakers CB19

  • Dr Mark Gurnell

    Mark Gurnell is Professor of Clinical Endocrinology and Clinical SubDean at the University of Cambridge. Together with his colleagues Professor Krish Chatterjee, Dr Carla Moran and Dr David Halsall, he co-directs a national/international referral service for patients with complex disorders of thyroid function, and has authored a number of articles and book chapters providing guidance on how to approach patients with so-called ‘funny’, ‘atypical’ or ‘perplexing’ thyroid function tests. He has a long-standing interest in genetic and acquired disorders of thyroid function, and has assembled a large cohort of patients with thyrotropinomas (TSHomas), who exhibit a rare but important cause of central hyperthyroidism. 

    His current programmes of research include:

    • genetic and acquired disorders of the hypothalamic-pituitary-thyroid axis 

    • molecular endocrine imaging with PET/CT & PET/MR

    • primary medical therapy in acromegaly

    • the endocrine basis of financial decision making

  • Dr Phillip Monaghan

    Phillip trained in the field of Clinical Biochemistry and has been a Clinical Scientist at The Christie Hospital and more recently The Christie Pathology Partnership for the last 8 years. Phillip is an Honorary Lecturer at the University of Manchester and is a member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Test Evaluation. He is a member of the UK NEQAS Steering Committee for Immunochemistry and is Associate Editor for the Annals of Clinical Biochemistry journal. Phillip was awarded the Silver Research Medal from the Royal College of Pathologists in 2012 for his work on serum cortisol measurement in Cushing’s disease; more recently, a Finalist at the Chief Scientific Officer’s Healthcare Science Awards. Phillip is Lead Healthcare Scientist for his Hospital.

  • Dr Dermot Neely

    Consultant in Clinical Biochemistry and Metabolic Medicine and Director of the Newcastle Supra-Regional Assay Services for Hormones and Cardiovascular Biomarkers, Lead Consultant for the Lipid and Metabolic Clinic, Royal Victoria Infirmary and Founder of the Lipid Specialists Advisory Group for the Regional Cardiovascular Network.  An expert adviser on the NICE Lipid Modification Guidelines in 2008 (CG67) and member of the Guideline Development Group for the CG181 guideline in 2012-14.  Standing Member of the NICE Diagnostics Advisory Committee 2014- present.  His research interests are in cardiovascular biomarkers, inherited lipid disorders and clinical trials of novel lipid lowering therapies.



To be held at The Royal College of Pathologists, 6 Alie Street, London E1 8QT